Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)
This study has been terminated.
(Lack of financial support)
Sponsor:
LifeBridge Health
Information provided by (Responsible Party):
Kevin Bliden, LifeBridge Health
ClinicalTrials.gov Identifier:
NCT01177592
First received: August 6, 2010
Last updated: April 11, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | January 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |